| 0 |
ADENOVIRAL ENCEPHALITIS |
3 |
0.2727 |
| 1 |
SERTOLI-CELL-ONLY SYNDROME |
4 |
0.2667 |
| 2 |
MALIGNANT TRANSFORMATION |
88 |
0.1960 |
| 3 |
BLOOD STEM CELL TRANSPLANT FAILURE |
36 |
0.1674 |
| 4 |
HERPETIC STOMATITIS |
3 |
0.1579 |
| 5 |
EPILEPSIA PARTIALIS CONTINUA |
6 |
0.1429 |
| 6 |
MENINGITIS EOSINOPHILIC |
4 |
0.1333 |
| 7 |
URETERIC COMPRESSION |
10 |
0.1316 |
| 8 |
HODGKIN'S DISEASE RECURRENT |
3 |
0.1250 |
| 9 |
PERITONEAL LESION |
10 |
0.1235 |
| 10 |
PERSISTENT GENERALISED LYMPHADENOPATHY |
3 |
0.1200 |
| 11 |
PNEUMOCEPHALUS |
38 |
0.1148 |
| 12 |
LYMPHADENITIS VIRAL |
4 |
0.1000 |
| 13 |
PLEUROPARENCHYMAL FIBROELASTOSIS |
10 |
0.0962 |
| 14 |
GASTROENTERITIS ADENOVIRUS |
15 |
0.0955 |
| 15 |
SPHEROCYTIC ANAEMIA |
6 |
0.0870 |
| 16 |
MENINGOENCEPHALITIS AMOEBIC |
5 |
0.0862 |
| 17 |
HEPATIC ANGIOSARCOMA |
6 |
0.0822 |
| 18 |
REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA |
8 |
0.0784 |
| 19 |
PNEUMONIA ADENOVIRAL |
15 |
0.0758 |
| 20 |
MANTLE CELL LYMPHOMA RECURRENT |
29 |
0.0667 |
| 21 |
METASTASES TO RETROPERITONEUM |
11 |
0.0647 |
| 22 |
ADENOVIRAL HEPATITIS |
15 |
0.0638 |
| 23 |
METASTASES TO MUSCLE |
11 |
0.0608 |
| 24 |
POLYCHROMASIA |
18 |
0.0600 |
| 25 |
AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANT |
5 |
0.0562 |
| 26 |
AUTOLOGOUS BONE MARROW TRANSPLANTATION THERAPY |
3 |
0.0536 |
| 27 |
IMPLANT SITE OEDEMA |
5 |
0.0515 |
| 28 |
PSEUDOMENINGOCELE |
8 |
0.0510 |
| 29 |
HUMAN HERPESVIRUS 7 INFECTION |
4 |
0.0506 |
| 30 |
CSF CULTURE POSITIVE |
5 |
0.0472 |
| 31 |
IMPLANT SITE NECROSIS |
4 |
0.0455 |
| 32 |
INTRACRANIAL HYPOTENSION |
29 |
0.0444 |
| 33 |
B-CELL LYMPHOMA RECURRENT |
24 |
0.0442 |
| 34 |
ACANTHAMOEBA INFECTION |
8 |
0.0426 |
| 35 |
OROPHARYNGEAL SQUAMOUS CELL CARCINOMA |
6 |
0.0417 |
| 36 |
ANTICONVULSANT TOXICITY |
2 |
0.0400 |
| 37 |
ENGRAFTMENT SYNDROME |
23 |
0.0389 |
| 38 |
METASTATIC LYMPHOMA |
15 |
0.0384 |
| 39 |
ALEXIA |
3 |
0.0370 |
| 40 |
MENINGOCOCCAL SEPSIS |
7 |
0.0368 |
| 41 |
CARDIOMYOPATHY ACUTE |
8 |
0.0365 |
| 42 |
ANAL SQUAMOUS CELL CARCINOMA |
11 |
0.0357 |
| 43 |
HERPES SIMPLEX TEST POSITIVE |
7 |
0.0352 |
| 44 |
TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA |
23 |
0.0351 |
| 45 |
DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT |
77 |
0.0349 |
| 46 |
AZOOSPERMIA |
13 |
0.0339 |
| 47 |
B-CELL LYMPHOMA REFRACTORY |
3 |
0.0337 |
| 48 |
MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS |
4 |
0.0328 |
| 49 |
SENSORY PROCESSING DISORDER |
5 |
0.0296 |
| 50 |
METASTASES TO CHEST WALL |
10 |
0.0288 |
| 51 |
RETICULOCYTOSIS |
6 |
0.0283 |
| 52 |
PROPIONIBACTERIUM INFECTION |
3 |
0.0280 |
| 53 |
ENGRAFT FAILURE |
8 |
0.0279 |
| 54 |
ENTEROBACTER SEPSIS |
10 |
0.0270 |
| 55 |
METASTASES TO SPLEEN |
11 |
0.0266 |
| 56 |
ENCEPHALITIS ENTEROVIRAL |
3 |
0.0265 |
| 57 |
HERPES SIMPLEX REACTIVATION |
10 |
0.0262 |
| 58 |
FUSOBACTERIUM INFECTION |
3 |
0.0256 |
| 59 |
HEPATIC INFECTION FUNGAL |
3 |
0.0250 |
| 60 |
THROMBOPHLEBITIS SEPTIC |
5 |
0.0244 |
| 61 |
FOLLICULAR LYMPHOMA |
21 |
0.0239 |
| 62 |
IDIOPATHIC PNEUMONIA SYNDROME |
7 |
0.0235 |
| 63 |
HUMAN HERPESVIRUS 8 INFECTION |
14 |
0.0230 |
| 64 |
QUADRANTANOPIA |
3 |
0.0229 |
| 65 |
PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL |
19 |
0.0225 |
| 66 |
JC VIRUS INFECTION |
36 |
0.0225 |
| 67 |
COLORECTAL ADENOCARCINOMA |
5 |
0.0223 |
| 68 |
AMERICAN TRYPANOSOMIASIS |
6 |
0.0222 |
| 69 |
METASTASES TO BONE MARROW |
11 |
0.0220 |
| 70 |
AUTOIMMUNE PANCYTOPENIA |
2 |
0.0220 |
| 71 |
CSF HIV ESCAPE SYNDROME |
3 |
0.0217 |
| 72 |
CANDIDA PNEUMONIA |
7 |
0.0217 |
| 73 |
STEM CELL TRANSPLANT |
54 |
0.0216 |
| 74 |
CAPNOCYTOPHAGA INFECTION |
2 |
0.0213 |
| 75 |
MALIGNANT GLIOMA |
3 |
0.0211 |
| 76 |
MYELODYSPLASTIC SYNDROME |
301 |
0.0208 |
| 77 |
HUMAN POLYOMAVIRUS INFECTION |
11 |
0.0207 |
| 78 |
ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES |
6 |
0.0205 |
| 79 |
SUBDURAL HYGROMA |
6 |
0.0197 |
| 80 |
MANTLE CELL LYMPHOMA |
30 |
0.0197 |
| 81 |
RESPIRATORY TRACT INFECTION FUNGAL |
10 |
0.0189 |
| 82 |
DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV |
6 |
0.0183 |
| 83 |
CYSTITIS VIRAL |
7 |
0.0183 |
| 84 |
MENINGITIS CHEMICAL |
4 |
0.0182 |
| 85 |
HUMAN HERPESVIRUS 6 ENCEPHALITIS |
5 |
0.0176 |
| 86 |
HEPATITIS CHRONIC ACTIVE |
3 |
0.0174 |
| 87 |
IMMUNE EFFECTOR CELL-ASSOCIATED HAEMATOTOXICITY |
3 |
0.0172 |
| 88 |
COLD TYPE HAEMOLYTIC ANAEMIA |
4 |
0.0170 |
| 89 |
CEREBROSPINAL FLUID RETENTION |
2 |
0.0169 |
| 90 |
KLEBSIELLA BACTERAEMIA |
16 |
0.0168 |
| 91 |
JEJUNAL PERFORATION |
4 |
0.0166 |
| 92 |
NEUTROPENIC COLITIS |
34 |
0.0164 |
| 93 |
BLINDNESS CORTICAL |
8 |
0.0163 |
| 94 |
SPLENIC LESION |
6 |
0.0162 |
| 95 |
HEMIANOPIA |
16 |
0.0161 |
| 96 |
HIP DEFORMITY |
7 |
0.0160 |
| 97 |
REFRACTORY ANAEMIA WITH AN EXCESS OF BLASTS |
5 |
0.0160 |
| 98 |
PULMONARY HILUM MASS |
3 |
0.0160 |
| 99 |
ANOSOGNOSIA |
12 |
0.0156 |
| 100 |
IMPLANT SITE REACTION |
7 |
0.0154 |
| 101 |
VOLVULUS OF SMALL BOWEL |
3 |
0.0152 |
| 102 |
REFRACTORY CYTOPENIA WITH UNILINEAGE DYSPLASIA |
3 |
0.0152 |
| 103 |
LENTIGO MALIGNA |
4 |
0.0149 |
| 104 |
GRANULOCYTES ABNORMAL |
3 |
0.0149 |
| 105 |
MICROPHTHALMOS |
4 |
0.0147 |
| 106 |
VENOOCCLUSIVE DISEASE |
36 |
0.0144 |
| 107 |
POST PROCEDURAL HYPOTHYROIDISM |
3 |
0.0142 |
| 108 |
AUTOIMMUNE THROMBOCYTOPENIA |
6 |
0.0139 |
| 109 |
CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER |
5 |
0.0137 |
| 110 |
EXTRADURAL HAEMATOMA |
18 |
0.0136 |
| 111 |
VENOOCCLUSIVE LIVER DISEASE |
67 |
0.0136 |
| 112 |
HEPATITIS E |
21 |
0.0133 |
| 113 |
BRUCELLOSIS |
2 |
0.0132 |
| 114 |
SECOND PRIMARY MALIGNANCY |
110 |
0.0132 |
| 115 |
CEREBRAL CYST |
9 |
0.0131 |
| 116 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
17 |
0.0129 |
| 117 |
URAEMIC ENCEPHALOPATHY |
4 |
0.0128 |
| 118 |
SCEDOSPORIUM INFECTION |
9 |
0.0127 |
| 119 |
ACUTE PULMONARY HISTOPLASMOSIS |
2 |
0.0126 |
| 120 |
INCISION SITE INFECTION |
11 |
0.0121 |
| 121 |
ACUTE MYELOMONOCYTIC LEUKAEMIA |
3 |
0.0119 |
| 122 |
CEREBROSPINAL FLUID LEAKAGE |
22 |
0.0119 |
| 123 |
BRAIN ABSCESS |
30 |
0.0118 |
| 124 |
ERYTHEMA INFECTIOSUM |
3 |
0.0117 |
| 125 |
HUMAN HERPESVIRUS 6 INFECTION |
22 |
0.0116 |
| 126 |
DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY |
11 |
0.0116 |
| 127 |
PROCEDURAL SITE REACTION |
6 |
0.0115 |
| 128 |
ENCEPHALITIS CYTOMEGALOVIRUS |
5 |
0.0114 |
| 129 |
TERMINAL ILEITIS |
7 |
0.0114 |
| 130 |
HUMAN HERPESVIRUS 6 INFECTION REACTIVATION |
4 |
0.0114 |
| 131 |
ADENOVIRUS INFECTION |
33 |
0.0114 |
| 132 |
VASOGENIC CEREBRAL OEDEMA |
8 |
0.0111 |
| 133 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
49 |
0.0111 |
| 134 |
ACUTE MYELOID LEUKAEMIA |
172 |
0.0110 |
| 135 |
CEREBRAL MASS EFFECT |
4 |
0.0110 |
| 136 |
CULTURE STOOL POSITIVE |
3 |
0.0109 |
| 137 |
BRAIN OEDEMA |
138 |
0.0109 |
| 138 |
PNEUMOCYSTIS JIROVECI INFECTION |
3 |
0.0108 |
| 139 |
INCISION SITE COMPLICATION |
9 |
0.0108 |
| 140 |
LUNG INFECTION PSEUDOMONAL |
6 |
0.0108 |
| 141 |
POSTOPERATIVE FEVER |
3 |
0.0107 |
| 142 |
URETERITIS |
3 |
0.0107 |
| 143 |
DISSEMINATED CRYPTOCOCCOSIS |
8 |
0.0106 |
| 144 |
PNEUMONIA MYCOPLASMAL |
8 |
0.0101 |
| 145 |
DIAPHRAGMATIC PARALYSIS |
6 |
0.0100 |
| 146 |
CLOSTRIDIUM COLITIS |
12 |
0.0099 |
| 147 |
FEBRILE BONE MARROW APLASIA |
42 |
0.0099 |
| 148 |
MYOCARDIAL RUPTURE |
3 |
0.0098 |
| 149 |
UREAPLASMA INFECTION |
4 |
0.0098 |
| 150 |
MUCOSAL INFLAMMATION |
256 |
0.0098 |
| 151 |
GASTROINTESTINAL FUNGAL INFECTION |
5 |
0.0097 |
| 152 |
WOUND DEBRIDEMENT |
4 |
0.0096 |
| 153 |
GLIOBLASTOMA MULTIFORME |
8 |
0.0095 |
| 154 |
BACTERIAL TRANSLOCATION |
3 |
0.0095 |
| 155 |
VIRAEMIA |
13 |
0.0094 |
| 156 |
MONOCLONAL IMMUNOGLOBULIN PRESENT |
7 |
0.0092 |
| 157 |
CNS VENTRICULITIS |
3 |
0.0092 |
| 158 |
GASTROENTERITIS ESCHERICHIA COLI |
5 |
0.0091 |
| 159 |
ASPERGILLUS INFECTION |
60 |
0.0091 |
| 160 |
BRAIN MASS |
3 |
0.0089 |
| 161 |
GAS GANGRENE |
3 |
0.0087 |
| 162 |
INFECTION REACTIVATION |
10 |
0.0087 |
| 163 |
DIFFUSE LARGE B-CELL LYMPHOMA |
66 |
0.0086 |
| 164 |
DISSEMINATED ASPERGILLOSIS |
4 |
0.0085 |
| 165 |
ANAEMIA HAEMOLYTIC AUTOIMMUNE |
7 |
0.0085 |
| 166 |
DYSPLASTIC NAEVUS |
3 |
0.0083 |
| 167 |
APLASIA |
16 |
0.0082 |
| 168 |
ESCHERICHIA BACTERAEMIA |
19 |
0.0081 |
| 169 |
SENSORIMOTOR DISORDER |
4 |
0.0080 |
| 170 |
VIRAL MYOCARDITIS |
3 |
0.0080 |
| 171 |
PERIPHERAL SENSORIMOTOR NEUROPATHY |
10 |
0.0080 |
| 172 |
PARAINFLUENZAE VIRUS INFECTION |
12 |
0.0079 |
| 173 |
LIPID METABOLISM DISORDER |
3 |
0.0078 |
| 174 |
BLOOD BILIRUBIN ABNORMAL |
10 |
0.0078 |
| 175 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
64 |
0.0078 |
| 176 |
PELVIC VENOUS THROMBOSIS |
11 |
0.0077 |
| 177 |
EXTRADURAL ABSCESS |
6 |
0.0076 |
| 178 |
ACUTE GRAFT VERSUS HOST DISEASE |
35 |
0.0076 |
| 179 |
BRAIN MIDLINE SHIFT |
4 |
0.0076 |
| 180 |
TRICHOSPORON INFECTION |
3 |
0.0074 |
| 181 |
PHARYNGEAL INFLAMMATION |
9 |
0.0074 |
| 182 |
CSF PROTEIN INCREASED |
6 |
0.0072 |
| 183 |
EPSTEIN-BARR VIRAEMIA |
8 |
0.0072 |
| 184 |
EXPANDED DISABILITY STATUS SCALE SCORE INCREASED |
9 |
0.0072 |
| 185 |
CHRONIC GRAFT VERSUS HOST DISEASE |
26 |
0.0072 |
| 186 |
BRAIN SCAN ABNORMAL |
4 |
0.0072 |
| 187 |
NEUTROPENIC SEPSIS |
51 |
0.0071 |
| 188 |
PNEUMONIA PRIMARY ATYPICAL |
4 |
0.0071 |
| 189 |
HAEMATOTOXICITY |
67 |
0.0070 |
| 190 |
BILIARY OBSTRUCTION |
9 |
0.0069 |
| 191 |
ENTEROCOCCAL INFECTION |
33 |
0.0068 |
| 192 |
QUADRIPARESIS |
11 |
0.0066 |
| 193 |
ENCEPHALITIS VIRAL |
8 |
0.0066 |
| 194 |
ASPERGILLUS TEST POSITIVE |
2 |
0.0065 |
| 195 |
CYTOMEGALOVIRUS ENTEROCOLITIS |
5 |
0.0065 |
| 196 |
APOPTOSIS |
2 |
0.0065 |
| 197 |
ZYGOMYCOSIS |
3 |
0.0064 |
| 198 |
POSTOPERATIVE INFECTION |
3 |
0.0063 |
| 199 |
CONJUNCTIVAL HAEMORRHAGE |
24 |
0.0063 |
| 200 |
GLIOMA |
4 |
0.0062 |
| 201 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER |
11 |
0.0062 |
| 202 |
KLEBSIELLA SEPSIS |
7 |
0.0062 |
| 203 |
ESCHERICHIA SEPSIS |
18 |
0.0062 |
| 204 |
CENTRAL NERVOUS SYSTEM INFECTION |
7 |
0.0061 |
| 205 |
NEUROLOGICAL DECOMPENSATION |
14 |
0.0060 |
| 206 |
MYELOPROLIFERATIVE NEOPLASM |
4 |
0.0060 |
| 207 |
FEBRILE NEUTROPENIA |
400 |
0.0060 |
| 208 |
CULTURE POSITIVE |
5 |
0.0060 |
| 209 |
INFERTILITY |
9 |
0.0060 |
| 210 |
CSF TEST ABNORMAL |
3 |
0.0060 |
| 211 |
HYPOGAMMAGLOBULINAEMIA |
39 |
0.0059 |
| 212 |
PNEUMONIA INFLUENZAL |
7 |
0.0059 |
| 213 |
OSTEOLYSIS |
12 |
0.0059 |
| 214 |
ENTEROVIRUS INFECTION |
5 |
0.0058 |
| 215 |
RELAPSING-REMITTING MULTIPLE SCLEROSIS |
5 |
0.0058 |
| 216 |
SUBILEUS |
12 |
0.0058 |
| 217 |
STEROID DEPENDENCE |
5 |
0.0057 |
| 218 |
MYOSITIS |
51 |
0.0057 |
| 219 |
BRONCHOPULMONARY ASPERGILLOSIS |
44 |
0.0057 |
| 220 |
ENTEROCOCCAL BACTERAEMIA |
6 |
0.0057 |
| 221 |
HEPATIC CYST |
19 |
0.0056 |
| 222 |
CANDIDA SEPSIS |
5 |
0.0056 |
| 223 |
STREPTOCOCCAL BACTERAEMIA |
6 |
0.0055 |
| 224 |
HAEMORRHAGIC INFARCTION |
3 |
0.0055 |
| 225 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
54 |
0.0054 |
| 226 |
CEREBRAL TOXOPLASMOSIS |
5 |
0.0054 |
| 227 |
HYPERMETROPIA |
5 |
0.0053 |
| 228 |
PULMONARY TOXICITY |
37 |
0.0052 |
| 229 |
CYSTITIS HAEMORRHAGIC |
21 |
0.0052 |
| 230 |
ENTEROCOLITIS |
30 |
0.0052 |
| 231 |
GRAFT VERSUS HOST DISEASE |
37 |
0.0051 |
| 232 |
SYSTEMIC MYCOSIS |
6 |
0.0051 |
| 233 |
PNEUMOCOCCAL INFECTION |
3 |
0.0051 |
| 234 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
14 |
0.0051 |
| 235 |
PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED |
3 |
0.0051 |
| 236 |
JUGULAR VEIN THROMBOSIS |
9 |
0.0051 |
| 237 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
7 |
0.0050 |
| 238 |
MENINGITIS BACTERIAL |
7 |
0.0049 |
| 239 |
ENTERITIS |
31 |
0.0048 |
| 240 |
LEUKOENCEPHALOPATHY |
18 |
0.0048 |
| 241 |
POSTICTAL STATE |
5 |
0.0048 |
| 242 |
HYDROCEPHALUS |
26 |
0.0048 |
| 243 |
CYTOMEGALOVIRUS VIRAEMIA |
21 |
0.0047 |
| 244 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
10 |
0.0047 |
| 245 |
HYPOREFLEXIA |
9 |
0.0047 |
| 246 |
PSEUDOMONAL BACTERAEMIA |
4 |
0.0047 |
| 247 |
PNEUMONIA CYTOMEGALOVIRAL |
9 |
0.0046 |
| 248 |
ABDOMINAL LYMPHADENOPATHY |
4 |
0.0046 |
| 249 |
THERAPY PARTIAL RESPONDER |
71 |
0.0045 |
| 250 |
CHRONIC MYELOMONOCYTIC LEUKAEMIA |
3 |
0.0045 |
| 251 |
CYTOMEGALOVIRUS INFECTION |
74 |
0.0044 |
| 252 |
CAECITIS |
2 |
0.0044 |
| 253 |
HEMIPLEGIA |
37 |
0.0044 |
| 254 |
OSTEOSCLEROSIS |
7 |
0.0044 |
| 255 |
SURGICAL PROCEDURE REPEATED |
3 |
0.0044 |
| 256 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
77 |
0.0043 |
| 257 |
PNEUMONIA KLEBSIELLA |
8 |
0.0043 |
| 258 |
EXTENSOR PLANTAR RESPONSE |
4 |
0.0043 |
| 259 |
ARACHNOIDITIS |
3 |
0.0043 |
| 260 |
OTOTOXICITY |
8 |
0.0043 |
| 261 |
PULMONARY VENO-OCCLUSIVE DISEASE |
3 |
0.0043 |
| 262 |
MEAN CELL VOLUME INCREASED |
11 |
0.0043 |
| 263 |
GRAFT VERSUS HOST DISEASE IN LIVER |
3 |
0.0042 |
| 264 |
CARDIOTOXICITY |
37 |
0.0041 |
| 265 |
CYTOPENIA |
50 |
0.0041 |
| 266 |
CEREBRAL VASOCONSTRICTION |
3 |
0.0041 |
| 267 |
PNEUMOCYSTIS JIROVECI PNEUMONIA |
9 |
0.0040 |
| 268 |
ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC |
3 |
0.0040 |
| 269 |
URINARY TRACT INFECTION BACTERIAL |
10 |
0.0040 |
| 270 |
CATHETER RELATED INFECTION |
4 |
0.0039 |
| 271 |
BK VIRUS INFECTION |
13 |
0.0039 |
| 272 |
EPSTEIN-BARR VIRUS INFECTION |
24 |
0.0038 |
| 273 |
FUNGAEMIA |
6 |
0.0038 |
| 274 |
OPHTHALMOPLEGIA |
6 |
0.0038 |
| 275 |
PNEUMONIA FUNGAL |
15 |
0.0038 |
| 276 |
WOUND DRAINAGE |
3 |
0.0038 |
| 277 |
INTRA-ABDOMINAL HAEMORRHAGE |
9 |
0.0038 |
| 278 |
RADIATION INJURY |
4 |
0.0038 |
| 279 |
LYMPHADENITIS |
9 |
0.0037 |
| 280 |
BLOOD IMMUNOGLOBULIN A INCREASED |
2 |
0.0037 |
| 281 |
IIIRD NERVE PARALYSIS |
3 |
0.0037 |
| 282 |
ENTEROCOCCAL SEPSIS |
3 |
0.0037 |
| 283 |
BRAIN HERNIATION |
11 |
0.0037 |
| 284 |
ATYPICAL PNEUMONIA |
11 |
0.0037 |
| 285 |
BLOOD CULTURE POSITIVE |
11 |
0.0037 |
| 286 |
RENAL ABSCESS |
3 |
0.0037 |
| 287 |
THROMBOCYTOPENIC PURPURA |
5 |
0.0037 |
| 288 |
PAPILLOMA VIRAL INFECTION |
6 |
0.0036 |
| 289 |
CENTRAL NERVOUS SYSTEM LYMPHOMA |
5 |
0.0036 |
| 290 |
COLLAPSE OF LUNG |
3 |
0.0036 |
| 291 |
BLOOD PH INCREASED |
2 |
0.0036 |
| 292 |
SEPTIC EMBOLUS |
3 |
0.0036 |
| 293 |
OESOPHAGEAL PERFORATION |
3 |
0.0036 |
| 294 |
CYTOMEGALOVIRUS CHORIORETINITIS |
7 |
0.0036 |
| 295 |
CARDIAC TAMPONADE |
17 |
0.0036 |
| 296 |
BONE FRAGMENTATION |
2 |
0.0036 |
| 297 |
NEOPLASM RECURRENCE |
12 |
0.0035 |
| 298 |
GASTROINTESTINAL TOXICITY |
17 |
0.0035 |
| 299 |
NEUROPATHY |
6 |
0.0035 |
| 300 |
COMPUTERISED TOMOGRAM ABNORMAL |
8 |
0.0035 |
| 301 |
CYTOMEGALOVIRUS COLITIS |
8 |
0.0035 |
| 302 |
WOUND INFECTION STAPHYLOCOCCAL |
6 |
0.0035 |
| 303 |
HYPOPITUITARISM |
6 |
0.0034 |
| 304 |
ORGANISING PNEUMONIA |
17 |
0.0034 |
| 305 |
LUNG INFILTRATION |
30 |
0.0034 |
| 306 |
BONE MARROW TOXICITY |
4 |
0.0034 |
| 307 |
BACTERIAL SEPSIS |
11 |
0.0034 |
| 308 |
VARICELLA ZOSTER VIRUS INFECTION |
7 |
0.0034 |
| 309 |
AREFLEXIA |
9 |
0.0034 |
| 310 |
BACTERAEMIA |
40 |
0.0034 |
| 311 |
KLEBSIELLA INFECTION |
17 |
0.0034 |
| 312 |
COCCIDIOIDOMYCOSIS |
4 |
0.0034 |
| 313 |
PARVOVIRUS B19 INFECTION |
3 |
0.0034 |
| 314 |
BASAL CELL CARCINOMA |
51 |
0.0033 |
| 315 |
VASOSPASM |
3 |
0.0033 |
| 316 |
ABULIA |
3 |
0.0032 |
| 317 |
URINARY TRACT INFECTION ENTEROCOCCAL |
3 |
0.0032 |
| 318 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
9 |
0.0032 |
| 319 |
PLATELET DISORDER |
8 |
0.0032 |
| 320 |
HEPATITIS B REACTIVATION |
10 |
0.0031 |
| 321 |
FOCAL SEGMENTAL GLOMERULOSCLEROSIS |
5 |
0.0031 |
| 322 |
HEPATOSPLENOMEGALY |
8 |
0.0031 |
| 323 |
LYMPHOMA |
48 |
0.0031 |
| 324 |
PURULENCE |
6 |
0.0031 |
| 325 |
ASPERGILLOSIS |
4 |
0.0031 |
| 326 |
DRUG CLEARANCE DECREASED |
4 |
0.0031 |
| 327 |
CYTOKINE RELEASE SYNDROME |
61 |
0.0030 |
| 328 |
DEAFNESS BILATERAL |
5 |
0.0029 |
| 329 |
RECURRENT CANCER |
12 |
0.0029 |
| 330 |
GLIOBLASTOMA |
5 |
0.0029 |
| 331 |
CAROTID ARTERIOSCLEROSIS |
3 |
0.0029 |
| 332 |
PUPIL FIXED |
5 |
0.0029 |
| 333 |
INTRACRANIAL PRESSURE INCREASED |
16 |
0.0029 |
| 334 |
TUMOUR NECROSIS |
3 |
0.0028 |
| 335 |
LYMPHOPENIA |
40 |
0.0028 |
| 336 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
14 |
0.0028 |
| 337 |
TACHYARRHYTHMIA |
7 |
0.0028 |
| 338 |
ACUTE GRAFT VERSUS HOST DISEASE IN LIVER |
2 |
0.0028 |
| 339 |
ANTIBODY TEST ABNORMAL |
2 |
0.0028 |
| 340 |
FINE MOTOR SKILL DYSFUNCTION |
8 |
0.0028 |
| 341 |
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL |
4 |
0.0028 |
| 342 |
GRAFT VERSUS HOST DISEASE IN SKIN |
6 |
0.0027 |
| 343 |
MENINGITIS |
18 |
0.0027 |
| 344 |
CARDIAC HYPERTROPHY |
3 |
0.0027 |
| 345 |
PSEUDOMONAS INFECTION |
23 |
0.0027 |
| 346 |
WOUND DEHISCENCE |
9 |
0.0027 |
| 347 |
CLOSTRIDIAL INFECTION |
9 |
0.0027 |
| 348 |
CYTOGENETIC ABNORMALITY |
3 |
0.0027 |
| 349 |
SKIN TOXICITY |
15 |
0.0027 |
| 350 |
CLOSTRIDIUM DIFFICILE COLITIS |
28 |
0.0026 |
| 351 |
PUPILS UNEQUAL |
3 |
0.0026 |
| 352 |
TUMOUR LYSIS SYNDROME |
23 |
0.0026 |
| 353 |
CEREBRAL VENTRICLE DILATATION |
3 |
0.0026 |
| 354 |
OSTEOCHONDROSIS |
3 |
0.0026 |
| 355 |
ASEPTIC NECROSIS BONE |
2 |
0.0026 |
| 356 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
13 |
0.0026 |
| 357 |
BLOOD FIBRINOGEN INCREASED |
2 |
0.0025 |
| 358 |
APPENDICECTOMY |
9 |
0.0025 |
| 359 |
PNEUMOCYSTIS JIROVECII INFECTION |
3 |
0.0025 |
| 360 |
NEPHROPATHY TOXIC |
28 |
0.0025 |
| 361 |
DISEASE PROGRESSION |
292 |
0.0025 |
| 362 |
SEPTIC SHOCK |
105 |
0.0024 |
| 363 |
GASTROINTESTINAL NECROSIS |
7 |
0.0024 |
| 364 |
CEREBRAL HAEMATOMA |
8 |
0.0024 |
| 365 |
STAPHYLOCOCCUS TEST POSITIVE |
5 |
0.0024 |
| 366 |
MALIGNANT PLEURAL EFFUSION |
4 |
0.0024 |
| 367 |
ESCHERICHIA URINARY TRACT INFECTION |
10 |
0.0024 |
| 368 |
NECROSIS |
13 |
0.0023 |
| 369 |
PHYSICAL DECONDITIONING |
6 |
0.0023 |
| 370 |
BONE MARROW DISORDER |
7 |
0.0023 |
| 371 |
THROMBOCYTOPENIA |
252 |
0.0023 |
| 372 |
CANDIDIASIS |
9 |
0.0022 |
| 373 |
TONGUE DRY |
3 |
0.0022 |
| 374 |
GRANULOCYTE COUNT DECREASED |
4 |
0.0022 |
| 375 |
HAEMOLYTIC URAEMIC SYNDROME |
5 |
0.0022 |
| 376 |
ADENOCARCINOMA GASTRIC |
2 |
0.0022 |
| 377 |
HERPES SIMPLEX |
14 |
0.0022 |
| 378 |
CARDIAC DYSFUNCTION |
8 |
0.0021 |
| 379 |
PLASMACYTOMA |
4 |
0.0021 |
| 380 |
CULTURE URINE POSITIVE |
3 |
0.0021 |
| 381 |
MYELITIS TRANSVERSE |
3 |
0.0021 |
| 382 |
ANTICONVULSANT DRUG LEVEL DECREASED |
3 |
0.0021 |
| 383 |
BONE MARROW TRANSPLANT |
4 |
0.0021 |
| 384 |
CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY |
3 |
0.0021 |
| 385 |
CANDIDA INFECTION |
35 |
0.0021 |
| 386 |
BONE MARROW FAILURE |
42 |
0.0021 |
| 387 |
PULMONARY SEPSIS |
3 |
0.0021 |
| 388 |
PULMONARY VALVE INCOMPETENCE |
3 |
0.0021 |
| 389 |
STATUS EPILEPTICUS |
23 |
0.0020 |
| 390 |
POST PROCEDURAL COMPLICATION |
39 |
0.0020 |
| 391 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
12 |
0.0020 |
| 392 |
STAPHYLOCOCCAL SEPSIS |
10 |
0.0020 |
| 393 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
32 |
0.0020 |
| 394 |
STAPHYLOCOCCAL INFECTION |
66 |
0.0020 |
| 395 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
19 |
0.0020 |
| 396 |
DEVICE RELATED SEPSIS |
4 |
0.0020 |
| 397 |
EMBOLISM VENOUS |
6 |
0.0020 |
| 398 |
GENITAL HERPES |
3 |
0.0020 |
| 399 |
INTESTINAL PERFORATION |
22 |
0.0020 |
| 400 |
ARTHRITIS BACTERIAL |
8 |
0.0019 |
| 401 |
BONE LESION |
7 |
0.0019 |
| 402 |
CAPILLARY LEAK SYNDROME |
4 |
0.0019 |
| 403 |
GASTROINTESTINAL INFLAMMATION |
15 |
0.0019 |
| 404 |
GASTROINTESTINAL STOMA COMPLICATION |
3 |
0.0019 |
| 405 |
COLITIS |
72 |
0.0019 |
| 406 |
PANCYTOPENIA |
106 |
0.0019 |
| 407 |
ENCEPHALITIS |
13 |
0.0019 |
| 408 |
NON-SMALL CELL LUNG CANCER |
9 |
0.0019 |
| 409 |
ATAXIA |
22 |
0.0019 |
| 410 |
MULTI-ORGAN FAILURE |
32 |
0.0018 |
| 411 |
STAPHYLOCOCCAL BACTERAEMIA |
8 |
0.0018 |
| 412 |
DRUG TOXICITY |
25 |
0.0018 |
| 413 |
WOUND INFECTION |
20 |
0.0018 |
| 414 |
DEVICE RELATED INFECTION |
28 |
0.0018 |
| 415 |
CARDIAC AMYLOIDOSIS |
2 |
0.0018 |
| 416 |
HEPATOTOXICITY |
40 |
0.0018 |
| 417 |
GLOMERULAR FILTRATION RATE DECREASED |
22 |
0.0018 |
| 418 |
PULMONARY ALVEOLAR HAEMORRHAGE |
10 |
0.0018 |
| 419 |
POSTOPERATIVE WOUND INFECTION |
12 |
0.0018 |
| 420 |
PNEUMONITIS |
48 |
0.0018 |
| 421 |
METASTASES TO MENINGES |
4 |
0.0018 |
| 422 |
TONGUE COATED |
3 |
0.0017 |
| 423 |
PARTIAL SEIZURES |
9 |
0.0017 |
| 424 |
BRONCHIOLITIS |
6 |
0.0017 |
| 425 |
ESCHERICHIA INFECTION |
14 |
0.0017 |
| 426 |
LEUKOPENIA |
85 |
0.0017 |
| 427 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
48 |
0.0017 |
| 428 |
LYMPHADENOPATHY |
59 |
0.0017 |
| 429 |
SOFT TISSUE INFECTION |
3 |
0.0016 |
| 430 |
TRANSPLANT FAILURE |
4 |
0.0016 |
| 431 |
HEPATOCELLULAR INJURY |
23 |
0.0016 |
| 432 |
HEPATIC LESION |
7 |
0.0016 |
| 433 |
MYELOSUPPRESSION |
58 |
0.0016 |
| 434 |
NEUROTOXICITY |
28 |
0.0016 |
| 435 |
OSTEITIS |
4 |
0.0016 |
| 436 |
HYPOPROTEINAEMIA |
3 |
0.0016 |
| 437 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
6 |
0.0016 |
| 438 |
NEUTROPENIA |
211 |
0.0016 |
| 439 |
SKIN NECROSIS |
8 |
0.0015 |
| 440 |
METASTASIS |
11 |
0.0015 |
| 441 |
PLASMA CELL MYELOMA RECURRENT |
5 |
0.0015 |
| 442 |
WOUND SECRETION |
6 |
0.0015 |
| 443 |
CHOLESTASIS |
29 |
0.0015 |
| 444 |
MYOPATHY |
13 |
0.0015 |
| 445 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
4 |
0.0015 |
| 446 |
HEPATITIS B |
9 |
0.0015 |
| 447 |
SMALL INTESTINAL HAEMORRHAGE |
3 |
0.0015 |
| 448 |
HEMIPARESIS |
25 |
0.0015 |
| 449 |
IMMUNOSUPPRESSION |
13 |
0.0015 |
| 450 |
SUBARACHNOID HAEMORRHAGE |
15 |
0.0015 |
| 451 |
B-CELL LYMPHOMA |
5 |
0.0015 |
| 452 |
VENOUS THROMBOSIS LIMB |
3 |
0.0015 |
| 453 |
SEPSIS |
162 |
0.0015 |
| 454 |
ADJUSTMENT DISORDER WITH DEPRESSED MOOD |
3 |
0.0014 |
| 455 |
BACTERIAL INFECTION |
27 |
0.0014 |
| 456 |
THROMBOTIC MICROANGIOPATHY |
14 |
0.0014 |
| 457 |
DILATATION VENTRICULAR |
3 |
0.0014 |
| 458 |
RENAL NEOPLASM |
3 |
0.0014 |
| 459 |
NEOPLASM PROGRESSION |
49 |
0.0014 |
| 460 |
LUNG NEOPLASM |
6 |
0.0014 |
| 461 |
RETINAL HAEMORRHAGE |
10 |
0.0014 |
| 462 |
TUMOUR HAEMORRHAGE |
4 |
0.0014 |
| 463 |
LYMPHOCYTOSIS |
3 |
0.0014 |
| 464 |
CEREBRAL INFARCTION |
34 |
0.0014 |
| 465 |
ILEUS |
17 |
0.0014 |
| 466 |
DISEASE RECURRENCE |
65 |
0.0014 |
| 467 |
SPINAL COLUMN INJURY |
3 |
0.0013 |
| 468 |
AGRANULOCYTOSIS |
25 |
0.0013 |
| 469 |
PSEUDOMEMBRANOUS COLITIS |
3 |
0.0013 |
| 470 |
NORMOCHROMIC NORMOCYTIC ANAEMIA |
4 |
0.0013 |
| 471 |
HEPATOCELLULAR DAMAGE |
3 |
0.0013 |
| 472 |
NYSTAGMUS |
7 |
0.0013 |
| 473 |
HAEMODIALYSIS |
11 |
0.0013 |
| 474 |
PNEUMONIA BACTERIAL |
12 |
0.0013 |
| 475 |
MULTIPLE-DRUG RESISTANCE |
4 |
0.0013 |
| 476 |
APPENDICITIS |
12 |
0.0013 |
| 477 |
PULMONARY HAEMORRHAGE |
10 |
0.0013 |
| 478 |
INFECTION |
183 |
0.0013 |
| 479 |
MALIGNANT NEOPLASM PROGRESSION |
129 |
0.0013 |
| 480 |
ACUTE LEUKAEMIA |
2 |
0.0012 |
| 481 |
STOMATITIS |
75 |
0.0012 |
| 482 |
SLOW SPEECH |
3 |
0.0012 |
| 483 |
HEPATITIS ACUTE |
8 |
0.0012 |
| 484 |
GRANULOCYTOPENIA |
7 |
0.0012 |
| 485 |
NEUROLOGICAL SYMPTOM |
7 |
0.0012 |
| 486 |
HERPES VIRUS INFECTION |
7 |
0.0012 |
| 487 |
CYTOLYTIC HEPATITIS |
4 |
0.0012 |
| 488 |
PERIPHERAL SENSORY NEUROPATHY |
7 |
0.0012 |
| 489 |
SYSTEMIC CANDIDA |
3 |
0.0012 |
| 490 |
RESPIRATORY FAILURE |
87 |
0.0012 |
| 491 |
SYMPTOM RECURRENCE |
7 |
0.0012 |
| 492 |
BLOOD AMYLASE INCREASED |
2 |
0.0012 |
| 493 |
WOUND COMPLICATION |
4 |
0.0012 |
| 494 |
VENTRICULAR DYSFUNCTION |
3 |
0.0012 |
| 495 |
DERMATITIS EXFOLIATIVE GENERALISED |
4 |
0.0011 |
| 496 |
APLASTIC ANAEMIA |
6 |
0.0011 |
| 497 |
ATELECTASIS |
11 |
0.0011 |
| 498 |
METASTASES TO LUNG |
13 |
0.0011 |
| 499 |
CONVULSION |
63 |
0.0011 |
| 500 |
HAEMOGLOBIN ABNORMAL |
7 |
0.0011 |
| 501 |
POLYNEUROPATHY |
13 |
0.0011 |
| 502 |
SERUM SICKNESS |
3 |
0.0011 |
| 503 |
LUNG CONSOLIDATION |
3 |
0.0011 |
| 504 |
ANGIOPATHY |
6 |
0.0011 |
| 505 |
NEUTROPHIL COUNT ABNORMAL |
3 |
0.0011 |
| 506 |
CLOSTRIDIUM DIFFICILE INFECTION |
23 |
0.0011 |
| 507 |
SUBDURAL HAEMATOMA |
15 |
0.0010 |
| 508 |
HYPOVOLAEMIC SHOCK |
5 |
0.0010 |
| 509 |
ADRENAL DISORDER |
2 |
0.0010 |
| 510 |
GUILLAIN-BARRE SYNDROME |
5 |
0.0010 |
| 511 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
9 |
0.0010 |
| 512 |
HYPOALBUMINAEMIA |
8 |
0.0010 |
| 513 |
APHASIA |
31 |
0.0010 |
| 514 |
LYMPHOPROLIFERATIVE DISORDER |
3 |
0.0010 |
| 515 |
VENOUS THROMBOSIS |
4 |
0.0010 |
| 516 |
TUBULOINTERSTITIAL NEPHRITIS |
19 |
0.0010 |
| 517 |
PNEUMOTHORAX |
16 |
0.0010 |
| 518 |
HAEMORRHAGE INTRACRANIAL |
15 |
0.0010 |
| 519 |
BLOOD BILIRUBIN INCREASED |
27 |
0.0010 |
| 520 |
RESPIRATORY TRACT INFECTION |
26 |
0.0010 |
| 521 |
TOXIC SKIN ERUPTION |
10 |
0.0010 |
| 522 |
ORGAN FAILURE |
4 |
0.0010 |
| 523 |
ACUTE RESPIRATORY FAILURE |
19 |
0.0010 |
| 524 |
PATHOGEN RESISTANCE |
9 |
0.0010 |
| 525 |
END STAGE RENAL DISEASE |
18 |
0.0010 |
| 526 |
PROSTATITIS |
3 |
0.0010 |
| 527 |
DYSAESTHESIA |
3 |
0.0010 |
| 528 |
CONCOMITANT DISEASE AGGRAVATED |
6 |
0.0010 |
| 529 |
HYPERBILIRUBINAEMIA |
10 |
0.0010 |
| 530 |
AORTIC VALVE INCOMPETENCE |
4 |
0.0009 |
| 531 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
7 |
0.0009 |
| 532 |
FUNGAL INFECTION |
31 |
0.0009 |
| 533 |
ABSCESS INTESTINAL |
2 |
0.0009 |
| 534 |
PSYCHOLOGICAL TRAUMA |
8 |
0.0009 |
| 535 |
MONOPLEGIA |
4 |
0.0009 |
| 536 |
LYMPHOCYTE COUNT INCREASED |
3 |
0.0009 |
| 537 |
HAEMODYNAMIC INSTABILITY |
7 |
0.0009 |
| 538 |
THROMBOSIS IN DEVICE |
3 |
0.0009 |
| 539 |
CEREBELLAR SYNDROME |
2 |
0.0009 |
| 540 |
SPINAL OSTEOARTHRITIS |
8 |
0.0009 |
| 541 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
3 |
0.0009 |
| 542 |
PARALYSIS |
13 |
0.0009 |
| 543 |
GASTRIC CANCER |
23 |
0.0009 |
| 544 |
DRUG ERUPTION |
16 |
0.0009 |
| 545 |
ILEUS PARALYTIC |
4 |
0.0009 |
| 546 |
ALANINE AMINOTRANSFERASE INCREASED |
55 |
0.0009 |
| 547 |
METASTASES TO SPINE |
3 |
0.0009 |
| 548 |
ACUTE PULMONARY OEDEMA |
5 |
0.0009 |
| 549 |
PAPILLOEDEMA |
4 |
0.0009 |
| 550 |
SUSPECTED OFF LABEL USE |
4 |
0.0009 |
| 551 |
NEUTROPHIL COUNT DECREASED |
36 |
0.0009 |
| 552 |
OSTEONECROSIS |
29 |
0.0009 |
| 553 |
CARDIOMYOPATHY |
13 |
0.0009 |
| 554 |
LARGE INTESTINE PERFORATION |
6 |
0.0009 |
| 555 |
POST PROCEDURAL INFECTION |
7 |
0.0009 |
| 556 |
STRESS CARDIOMYOPATHY |
5 |
0.0009 |
| 557 |
MULTIPLE MYELOMA |
4 |
0.0009 |
| 558 |
ENCEPHALOPATHY |
21 |
0.0009 |
| 559 |
PULMONARY EMBOLISM |
81 |
0.0009 |
| 560 |
THROMBOTIC THROMBOCYTOPENIC PURPURA |
3 |
0.0009 |
| 561 |
COVID-19 PNEUMONIA |
10 |
0.0008 |
| 562 |
EMBOLISM |
7 |
0.0008 |
| 563 |
SARCOIDOSIS |
4 |
0.0008 |
| 564 |
VIRAL INFECTION |
28 |
0.0008 |
| 565 |
NERVOUS SYSTEM DISORDER |
26 |
0.0008 |
| 566 |
FAECAL INCONTINENCE |
4 |
0.0008 |
| 567 |
PERICARDIAL EFFUSION |
19 |
0.0008 |
| 568 |
AUTOIMMUNE DISORDER |
8 |
0.0008 |
| 569 |
HEPATITIS |
21 |
0.0008 |
| 570 |
NEUROPATHY PERIPHERAL |
78 |
0.0008 |
| 571 |
HYPOPHOSPHATAEMIA |
6 |
0.0008 |
| 572 |
RENAL FAILURE ACUTE |
34 |
0.0008 |
| 573 |
DERMATITIS EXFOLIATIVE |
4 |
0.0008 |
| 574 |
PROTEIN TOTAL DECREASED |
3 |
0.0008 |
| 575 |
LYMPHOCYTE COUNT DECREASED |
14 |
0.0008 |
| 576 |
DEEP VEIN THROMBOSIS |
51 |
0.0008 |
| 577 |
PROCEDURAL COMPLICATION |
6 |
0.0008 |
| 578 |
COAGULOPATHY |
13 |
0.0008 |
| 579 |
ENDOCARDITIS |
4 |
0.0008 |
| 580 |
CACHEXIA |
4 |
0.0008 |
| 581 |
EJECTION FRACTION DECREASED |
12 |
0.0008 |
| 582 |
PROSTATOMEGALY |
3 |
0.0008 |
| 583 |
SCAR |
13 |
0.0008 |
| 584 |
IMMUNE SYSTEM DISORDER |
10 |
0.0008 |
| 585 |
MENTAL STATUS CHANGES |
21 |
0.0008 |
| 586 |
INTENTIONAL PRODUCT USE ISSUE |
66 |
0.0008 |
| 587 |
CEREBRAL ATROPHY |
3 |
0.0008 |
| 588 |
DRUG RESISTANCE |
19 |
0.0007 |
| 589 |
GOITRE |
3 |
0.0007 |
| 590 |
HYPERURICAEMIA |
3 |
0.0007 |
| 591 |
DEAFNESS |
19 |
0.0007 |
| 592 |
EUGLYCAEMIC DIABETIC KETOACIDOSIS |
3 |
0.0007 |
| 593 |
PYREXIA |
242 |
0.0007 |
| 594 |
DRUG LEVEL DECREASED |
7 |
0.0007 |
| 595 |
HYPOVOLAEMIA |
4 |
0.0007 |
| 596 |
METASTASES TO LIVER |
12 |
0.0007 |
| 597 |
ABDOMINAL ABSCESS |
3 |
0.0007 |
| 598 |
PULMONARY FIBROSIS |
13 |
0.0007 |
| 599 |
MENINGITIS ASEPTIC |
3 |
0.0007 |
| 600 |
SUDDEN DEATH |
7 |
0.0007 |
| 601 |
HYPERTHERMIA |
5 |
0.0007 |
| 602 |
CHEST X-RAY ABNORMAL |
2 |
0.0007 |
| 603 |
BRAIN NATRIURETIC PEPTIDE INCREASED |
2 |
0.0006 |
| 604 |
BRAIN DEATH |
2 |
0.0006 |
| 605 |
OLIGURIA |
4 |
0.0006 |
| 606 |
OESOPHAGITIS |
7 |
0.0006 |
| 607 |
PNEUMONIA |
206 |
0.0006 |
| 608 |
DERMATITIS ALLERGIC |
8 |
0.0006 |
| 609 |
PRODUCT USE IN UNAPPROVED INDICATION |
157 |
0.0006 |
| 610 |
RENAL TUBULAR NECROSIS |
6 |
0.0006 |
| 611 |
PLATELET COUNT DECREASED |
65 |
0.0006 |
| 612 |
NASAL POLYPS |
3 |
0.0006 |
| 613 |
ANAEMIA |
116 |
0.0006 |
| 614 |
WALKING AID USER |
4 |
0.0006 |
| 615 |
DIABETIC NEUROPATHY |
3 |
0.0006 |
| 616 |
ABDOMINAL TENDERNESS |
3 |
0.0006 |
| 617 |
HYPERNATRAEMIA |
3 |
0.0006 |
| 618 |
LEFT VENTRICULAR DYSFUNCTION |
4 |
0.0006 |
| 619 |
HYPOXIA |
21 |
0.0006 |
| 620 |
ATRIAL FIBRILLATION |
58 |
0.0006 |
| 621 |
OFF LABEL USE |
521 |
0.0006 |
| 622 |
EMPHYSEMA |
6 |
0.0006 |
| 623 |
LUNG DISORDER |
29 |
0.0006 |
| 624 |
HERPES ZOSTER |
34 |
0.0006 |
| 625 |
EYELID PTOSIS |
6 |
0.0006 |
| 626 |
CEREBRAL HAEMORRHAGE |
21 |
0.0006 |
| 627 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
6 |
0.0006 |
| 628 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
2 |
0.0006 |
| 629 |
PLEURAL EFFUSION |
35 |
0.0006 |
| 630 |
PETECHIAE |
6 |
0.0006 |
| 631 |
CAROTID ARTERY STENOSIS |
2 |
0.0006 |
| 632 |
DISSEMINATED INTRAVASCULAR COAGULATION |
8 |
0.0006 |
| 633 |
ASPARTATE AMINOTRANSFERASE INCREASED |
30 |
0.0006 |
| 634 |
JAUNDICE |
15 |
0.0006 |
| 635 |
RASH PUSTULAR |
4 |
0.0005 |
| 636 |
IMPAIRED HEALING |
18 |
0.0005 |
| 637 |
JAW DISORDER |
3 |
0.0005 |
| 638 |
INTESTINAL ISCHAEMIA |
3 |
0.0005 |
| 639 |
ACUTE KIDNEY INJURY |
83 |
0.0005 |
| 640 |
RASH MACULO-PAPULAR |
12 |
0.0005 |
| 641 |
SQUAMOUS CELL CARCINOMA |
5 |
0.0005 |
| 642 |
HEPATIC FAILURE |
16 |
0.0005 |
| 643 |
PERONEAL NERVE PALSY |
3 |
0.0005 |
| 644 |
COMA |
25 |
0.0005 |
| 645 |
RENAL IMPAIRMENT |
44 |
0.0005 |
| 646 |
PNEUMONIA ASPIRATION |
13 |
0.0005 |
| 647 |
PULMONARY OEDEMA |
23 |
0.0005 |
| 648 |
ILL-DEFINED DISORDER |
31 |
0.0005 |
| 649 |
ASCITES |
15 |
0.0005 |
| 650 |
HEPATOMEGALY |
5 |
0.0005 |
| 651 |
ALTERED STATE OF CONSCIOUSNESS |
11 |
0.0005 |
| 652 |
PROTHROMBIN TIME PROLONGED |
3 |
0.0005 |
| 653 |
RESPIRATORY DISORDER |
15 |
0.0005 |
| 654 |
THYROID CANCER |
6 |
0.0005 |
| 655 |
INTERSTITIAL LUNG DISEASE |
24 |
0.0005 |
| 656 |
SINUS TACHYCARDIA |
7 |
0.0005 |
| 657 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
27 |
0.0005 |
| 658 |
EPILEPSY |
15 |
0.0005 |
| 659 |
THERAPY NON-RESPONDER |
22 |
0.0005 |
| 660 |
FLUID OVERLOAD |
7 |
0.0005 |
| 661 |
GASTROENTERITIS |
7 |
0.0005 |
| 662 |
DYSPNOEA EXERTIONAL |
18 |
0.0005 |
| 663 |
CARDIAC FAILURE |
38 |
0.0005 |
| 664 |
HEPATIC CYTOLYSIS |
6 |
0.0005 |
| 665 |
HYPOTHYROIDISM |
15 |
0.0005 |
| 666 |
IMMUNODEFICIENCY |
7 |
0.0005 |
| 667 |
PYELONEPHRITIS |
4 |
0.0005 |
| 668 |
ASPIRATION |
5 |
0.0005 |
| 669 |
CORONAVIRUS INFECTION |
3 |
0.0005 |
| 670 |
LUNG INFECTION |
7 |
0.0005 |
| 671 |
VENTRICULAR FIBRILLATION |
5 |
0.0004 |
| 672 |
URINARY RETENTION |
15 |
0.0004 |
| 673 |
BRAIN NEOPLASM MALIGNANT |
2 |
0.0004 |
| 674 |
GASTROINTESTINAL INFECTION |
4 |
0.0004 |
| 675 |
MITRAL VALVE INCOMPETENCE |
5 |
0.0004 |
| 676 |
BLOOD PRESSURE SYSTOLIC DECREASED |
2 |
0.0004 |
| 677 |
NEPHROTIC SYNDROME |
3 |
0.0004 |
| 678 |
SKIN LESION |
12 |
0.0004 |
| 679 |
BRAIN NEOPLASM |
4 |
0.0004 |
| 680 |
NEOPLASM |
5 |
0.0004 |
| 681 |
GASTRIC HAEMORRHAGE |
5 |
0.0004 |
| 682 |
UROSEPSIS |
4 |
0.0004 |
| 683 |
TOXICITY TO VARIOUS AGENTS |
73 |
0.0004 |
| 684 |
RENAL FAILURE |
57 |
0.0004 |
| 685 |
SPLENOMEGALY |
5 |
0.0004 |
| 686 |
VENTRICULAR TACHYCARDIA |
7 |
0.0004 |
| 687 |
TONGUE DISORDER |
3 |
0.0004 |
| 688 |
HEPATITIS C |
5 |
0.0004 |
| 689 |
NO THERAPEUTIC RESPONSE |
5 |
0.0004 |
| 690 |
LIVER INJURY |
10 |
0.0004 |
| 691 |
CARDIOMEGALY |
5 |
0.0004 |
| 692 |
BREATH SOUNDS ABNORMAL |
2 |
0.0004 |
| 693 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
16 |
0.0004 |
| 694 |
CYST |
5 |
0.0004 |
| 695 |
PULMONARY MASS |
6 |
0.0004 |
| 696 |
TOOTH EXTRACTION |
5 |
0.0004 |
| 697 |
INTESTINAL OBSTRUCTION |
15 |
0.0004 |
| 698 |
BODY TEMPERATURE INCREASED |
8 |
0.0004 |
| 699 |
HYPOKALAEMIA |
18 |
0.0004 |
| 700 |
MYDRIASIS |
5 |
0.0004 |
| 701 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
10 |
0.0004 |
| 702 |
OSTEOMYELITIS |
7 |
0.0004 |
| 703 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
9 |
0.0004 |
| 704 |
C-REACTIVE PROTEIN INCREASED |
14 |
0.0004 |
| 705 |
FOLLICULITIS |
4 |
0.0004 |
| 706 |
PULMONARY CONGESTION |
5 |
0.0004 |
| 707 |
INCONTINENCE |
4 |
0.0004 |
| 708 |
LIVER FUNCTION TEST ABNORMAL |
11 |
0.0004 |
| 709 |
BLOOD DISORDER |
3 |
0.0004 |
| 710 |
RHINITIS |
3 |
0.0004 |
| 711 |
ANAL ABSCESS |
2 |
0.0004 |
| 712 |
OEDEMA |
20 |
0.0004 |
| 713 |
PROTEINURIA |
7 |
0.0004 |
| 714 |
RESPIRATORY DISTRESS |
10 |
0.0004 |
| 715 |
ACUTE CORONARY SYNDROME |
3 |
0.0004 |
| 716 |
CARDIOGENIC SHOCK |
5 |
0.0003 |
| 717 |
HAEMATOMA |
9 |
0.0003 |
| 718 |
PULMONARY ARTERIAL HYPERTENSION |
5 |
0.0003 |
| 719 |
ACUTE MYOCARDIAL INFARCTION |
10 |
0.0003 |
| 720 |
PURPURA |
3 |
0.0003 |
| 721 |
ISCHAEMIC STROKE |
6 |
0.0003 |
| 722 |
PLASMA CELL MYELOMA |
13 |
0.0003 |
| 723 |
MOUTH ULCERATION |
7 |
0.0003 |
| 724 |
WHITE BLOOD CELL COUNT DECREASED |
36 |
0.0003 |
| 725 |
SMALL INTESTINAL OBSTRUCTION |
4 |
0.0003 |
| 726 |
GENERALISED OEDEMA |
4 |
0.0003 |
| 727 |
FEMUR FRACTURE |
10 |
0.0003 |
| 728 |
PHARYNGITIS |
4 |
0.0003 |
| 729 |
HEPATIC FUNCTION ABNORMAL |
12 |
0.0003 |
| 730 |
HEPATIC ENCEPHALOPATHY |
3 |
0.0003 |
| 731 |
COGNITIVE DISORDER |
15 |
0.0003 |
| 732 |
DIARRHOEA HAEMORRHAGIC |
3 |
0.0003 |
| 733 |
LEUKAEMIA |
3 |
0.0003 |
| 734 |
CELLULITIS |
16 |
0.0003 |
| 735 |
DELIRIUM |
11 |
0.0003 |
| 736 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
7 |
0.0003 |
| 737 |
GASTRIC ULCER |
6 |
0.0003 |
| 738 |
TACHYCARDIA |
28 |
0.0003 |
| 739 |
CARDIAC ARREST |
26 |
0.0003 |
| 740 |
TRANSAMINASES INCREASED |
7 |
0.0003 |
| 741 |
TREATMENT FAILURE |
26 |
0.0003 |
| 742 |
ANOREXIA |
4 |
0.0003 |
| 743 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
4 |
0.0003 |
| 744 |
MUSCULAR WEAKNESS |
35 |
0.0003 |
| 745 |
TINNITUS |
14 |
0.0003 |
| 746 |
ORAL CANDIDIASIS |
4 |
0.0003 |
| 747 |
GENERALISED TONIC-CLONIC SEIZURE |
5 |
0.0003 |
| 748 |
HAEMOGLOBIN DECREASED |
31 |
0.0003 |
| 749 |
BLOOD UREA INCREASED |
5 |
0.0003 |
| 750 |
MALIGNANT MELANOMA |
4 |
0.0003 |
| 751 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
5 |
0.0003 |
| 752 |
BRONCHIECTASIS |
2 |
0.0003 |
| 753 |
MULTIPLE SCLEROSIS |
14 |
0.0003 |
| 754 |
MOBILITY DECREASED |
21 |
0.0003 |
| 755 |
CENTRAL NERVOUS SYSTEM LESION |
4 |
0.0003 |
| 756 |
DRUG INTERACTION |
46 |
0.0003 |
| 757 |
PERITONITIS |
6 |
0.0003 |
| 758 |
COORDINATION ABNORMAL |
4 |
0.0003 |
| 759 |
AMENORRHOEA |
5 |
0.0003 |
| 760 |
HYPOTENSION |
56 |
0.0003 |
| 761 |
VISUAL ACUITY REDUCED |
9 |
0.0003 |
| 762 |
HYPERTENSIVE CRISIS |
3 |
0.0003 |
| 763 |
MALNUTRITION |
3 |
0.0003 |
| 764 |
HAEMORRHAGE |
28 |
0.0003 |
| 765 |
FISTULA |
3 |
0.0003 |
| 766 |
BLOOD CALCIUM DECREASED |
3 |
0.0003 |
| 767 |
HYPONATRAEMIA |
15 |
0.0003 |
| 768 |
HYPOCALCAEMIA |
5 |
0.0003 |
| 769 |
SHOCK |
6 |
0.0003 |
| 770 |
DRUG ADMINISTRATION ERROR |
8 |
0.0003 |
| 771 |
SEIZURE |
30 |
0.0003 |
| 772 |
GENERAL PHYSICAL HEALTH DETERIORATION |
30 |
0.0003 |
| 773 |
VASCULITIS |
3 |
0.0003 |
| 774 |
ORAL HERPES |
5 |
0.0003 |
| 775 |
SPINAL PAIN |
3 |
0.0003 |
| 776 |
ARTERIAL OCCLUSIVE DISEASE |
2 |
0.0003 |
| 777 |
CYANOSIS |
4 |
0.0003 |
| 778 |
ARRHYTHMIA |
12 |
0.0003 |
| 779 |
BLOOD IRON DECREASED |
3 |
0.0003 |
| 780 |
HAEMATOCRIT DECREASED |
5 |
0.0003 |
| 781 |
BLOOD ALBUMIN DECREASED |
2 |
0.0003 |
| 782 |
DIARRHOEA |
162 |
0.0003 |
| 783 |
COVID-19 |
44 |
0.0003 |
| 784 |
ATRIAL FLUTTER |
2 |
0.0003 |
| 785 |
SENSORY DISTURBANCE |
4 |
0.0002 |
| 786 |
ADRENAL INSUFFICIENCY |
3 |
0.0002 |
| 787 |
HYPERGLYCAEMIA |
9 |
0.0002 |
| 788 |
ASPHYXIA |
2 |
0.0002 |
| 789 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
6 |
0.0002 |
| 790 |
CARDIO-RESPIRATORY ARREST |
10 |
0.0002 |
| 791 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
7 |
0.0002 |
| 792 |
PERICARDITIS |
4 |
0.0002 |
| 793 |
CIRCULATORY COLLAPSE |
4 |
0.0002 |
| 794 |
INFLAMMATION |
12 |
0.0002 |
| 795 |
BLOOD MAGNESIUM DECREASED |
2 |
0.0002 |
| 796 |
CARDIAC MURMUR |
2 |
0.0002 |
| 797 |
DIPLOPIA |
6 |
0.0002 |
| 798 |
BRONCHITIS |
17 |
0.0002 |
| 799 |
HYPERKALAEMIA |
8 |
0.0002 |
| 800 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
16 |
0.0002 |
| 801 |
CHILLS |
26 |
0.0002 |
| 802 |
HEAD INJURY |
7 |
0.0002 |
| 803 |
TACHYPNOEA |
3 |
0.0002 |
| 804 |
ACUTE HEPATIC FAILURE |
3 |
0.0002 |
| 805 |
BONE DISORDER |
4 |
0.0002 |
| 806 |
CONFUSIONAL STATE |
35 |
0.0002 |
| 807 |
DIVERTICULITIS |
6 |
0.0002 |
| 808 |
LACTIC ACIDOSIS |
7 |
0.0002 |
| 809 |
CONJUNCTIVITIS |
4 |
0.0002 |
| 810 |
HYPOMAGNESAEMIA |
3 |
0.0002 |
| 811 |
SEASONAL ALLERGY |
3 |
0.0002 |
| 812 |
INFUSION RELATED REACTION |
14 |
0.0002 |
| 813 |
EPISTAXIS |
15 |
0.0002 |
| 814 |
BLOOD POTASSIUM DECREASED |
6 |
0.0002 |
| 815 |
BRAIN INJURY |
2 |
0.0002 |
| 816 |
PRODUCT USE ISSUE |
37 |
0.0002 |
| 817 |
BLINDNESS |
8 |
0.0002 |
| 818 |
PULMONARY HYPERTENSION |
4 |
0.0002 |
| 819 |
DRUG-INDUCED LIVER INJURY |
6 |
0.0002 |
| 820 |
DERMATITIS |
4 |
0.0002 |
| 821 |
BRADYCARDIA |
10 |
0.0002 |
| 822 |
ABSCESS |
3 |
0.0002 |
| 823 |
EATING DISORDER |
4 |
0.0002 |
| 824 |
BONE PAIN |
11 |
0.0002 |
| 825 |
BLOOD CREATININE INCREASED |
12 |
0.0002 |
| 826 |
PRODUCT PRESCRIBING ISSUE |
4 |
0.0002 |
| 827 |
MELAENA |
4 |
0.0002 |
| 828 |
HAEMOPTYSIS |
5 |
0.0002 |
| 829 |
VOMITING |
84 |
0.0002 |
| 830 |
LETHARGY |
10 |
0.0002 |
| 831 |
SPEECH DISORDER |
9 |
0.0002 |
| 832 |
URINARY INCONTINENCE |
5 |
0.0002 |
| 833 |
CHOLECYSTITIS |
2 |
0.0002 |
| 834 |
GASTROINTESTINAL HAEMORRHAGE |
14 |
0.0002 |
| 835 |
TOOTHACHE |
3 |
0.0002 |
| 836 |
THERAPEUTIC RESPONSE DECREASED |
10 |
0.0002 |
| 837 |
NEURALGIA |
4 |
0.0002 |
| 838 |
URINARY TRACT INFECTION |
28 |
0.0002 |
| 839 |
ABDOMINAL PAIN |
38 |
0.0002 |
| 840 |
OSTEONECROSIS OF JAW |
4 |
0.0002 |
| 841 |
CONDITION AGGRAVATED |
49 |
0.0002 |
| 842 |
HEPATIC STEATOSIS |
3 |
0.0002 |
| 843 |
MUSCULOSKELETAL DISORDER |
3 |
0.0002 |
| 844 |
HERNIA |
3 |
0.0002 |
| 845 |
SKIN ULCER |
4 |
0.0002 |
| 846 |
DRUG INEFFECTIVE |
202 |
0.0002 |
| 847 |
CHOLELITHIASIS |
5 |
0.0002 |
| 848 |
ASTHENIA |
57 |
0.0002 |
| 849 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
3 |
0.0002 |
| 850 |
DISORIENTATION |
6 |
0.0002 |
| 851 |
CARDIAC FAILURE CONGESTIVE |
12 |
0.0001 |
| 852 |
SOMNOLENCE |
30 |
0.0001 |
| 853 |
TRANSIENT ISCHAEMIC ATTACK |
5 |
0.0001 |
| 854 |
FREQUENT BOWEL MOVEMENTS |
4 |
0.0001 |
| 855 |
PRODUCTIVE COUGH |
7 |
0.0001 |
| 856 |
POLLAKIURIA |
6 |
0.0001 |
| 857 |
DEHYDRATION |
19 |
0.0001 |
| 858 |
OXYGEN SATURATION DECREASED |
8 |
0.0001 |
| 859 |
INTERNATIONAL NORMALISED RATIO INCREASED |
4 |
0.0001 |
| 860 |
DRY EYE |
7 |
0.0001 |
| 861 |
RED BLOOD CELL COUNT DECREASED |
4 |
0.0001 |
| 862 |
BREAST CANCER |
13 |
0.0001 |
| 863 |
INTERVERTEBRAL DISC PROTRUSION |
3 |
0.0001 |
| 864 |
APATHY |
2 |
0.0001 |
| 865 |
DYSURIA |
5 |
0.0001 |
| 866 |
DEATH |
117 |
0.0001 |
| 867 |
GASTROINTESTINAL DISORDER |
12 |
0.0001 |
| 868 |
CORONARY ARTERY DISEASE |
4 |
0.0001 |
| 869 |
RASH |
57 |
0.0001 |
| 870 |
COUGH |
36 |
0.0001 |
| 871 |
HYPERTENSION |
27 |
0.0001 |
| 872 |
CYSTITIS |
4 |
0.0001 |
| 873 |
METABOLIC ACIDOSIS |
4 |
0.0001 |
| 874 |
NIGHT SWEATS |
4 |
0.0001 |
| 875 |
DYSPNOEA |
69 |
0.0001 |
| 876 |
PARAESTHESIA |
19 |
0.0001 |
| 877 |
GAIT DISTURBANCE |
23 |
0.0001 |
| 878 |
DIABETES MELLITUS |
9 |
0.0001 |
| 879 |
UNRESPONSIVE TO STIMULI |
3 |
0.0001 |
| 880 |
NAUSEA |
91 |
0.0001 |
| 881 |
HEADACHE |
72 |
0.0001 |
| 882 |
DRUG INTOLERANCE |
11 |
0.0001 |
| 883 |
LIVER DISORDER |
5 |
0.0001 |
| 884 |
PROSTATE CANCER |
9 |
0.0001 |
| 885 |
WEIGHT INCREASED |
25 |
0.0001 |
| 886 |
DRUG EFFECT DECREASED |
6 |
0.0001 |
| 887 |
SKIN DISCOLOURATION |
5 |
0.0001 |
| 888 |
UPPER RESPIRATORY TRACT INFECTION |
5 |
0.0001 |
| 889 |
BLOOD SODIUM DECREASED |
2 |
0.0001 |
| 890 |
PAIN IN JAW |
3 |
0.0001 |
| 891 |
NEOPLASM MALIGNANT |
7 |
0.0001 |
| 892 |
DECREASED APPETITE |
24 |
0.0001 |
| 893 |
PREMATURE BABY |
3 |
0.0001 |
| 894 |
INFLUENZA |
11 |
0.0001 |
| 895 |
DRY MOUTH |
8 |
0.0001 |
| 896 |
PSORIATIC ARTHROPATHY |
4 |
0.0001 |
| 897 |
FLUID RETENTION |
5 |
0.0001 |
| 898 |
THERAPY CESSATION |
5 |
0.0001 |
| 899 |
LUNG NEOPLASM MALIGNANT |
4 |
0.0001 |
| 900 |
ROAD TRAFFIC ACCIDENT |
4 |
0.0001 |
| 901 |
MEMORY IMPAIRMENT |
13 |
0.0001 |
| 902 |
CEREBROVASCULAR ACCIDENT |
16 |
0.0001 |
| 903 |
RECTAL HAEMORRHAGE |
4 |
0.0001 |
| 904 |
UNEVALUABLE EVENT |
7 |
0.0001 |
| 905 |
ANAPHYLACTIC REACTION |
5 |
0.0001 |
| 906 |
SKIN DISORDER |
3 |
0.0001 |
| 907 |
WEIGHT DECREASED |
25 |
0.0001 |
| 908 |
TYPE 2 DIABETES MELLITUS |
3 |
0.0001 |
| 909 |
DEPRESSION |
20 |
0.0001 |
| 910 |
SINUSITIS |
9 |
0.0001 |
| 911 |
HAEMATURIA |
3 |
0.0001 |
| 912 |
MULTIPLE SCLEROSIS RELAPSE |
6 |
0.0001 |
| 913 |
CARDIAC DISORDER |
8 |
0.0001 |
| 914 |
RASH ERYTHEMATOUS |
4 |
0.0001 |
| 915 |
ALOPECIA |
16 |
0.0001 |
| 916 |
HYPOAESTHESIA |
12 |
0.0001 |
| 917 |
ABDOMINAL PAIN LOWER |
2 |
0.0001 |
| 918 |
LOSS OF CONSCIOUSNESS |
10 |
0.0001 |
| 919 |
ANAPHYLACTIC SHOCK |
2 |
0.0001 |
| 920 |
FATIGUE |
60 |
0.0001 |
| 921 |
DISTURBANCE IN ATTENTION |
4 |
0.0001 |
| 922 |
OEDEMA PERIPHERAL |
9 |
0.0001 |
| 923 |
DYSPHAGIA |
7 |
0.0001 |
| 924 |
HEPATIC ENZYME INCREASED |
5 |
0.0001 |
| 925 |
VISION BLURRED |
10 |
0.0001 |
| 926 |
INJURY |
5 |
0.0001 |
| 927 |
SLEEP DISORDER |
5 |
0.0001 |
| 928 |
OSTEOARTHRITIS |
3 |
0.0001 |
| 929 |
HYPERSENSITIVITY |
13 |
0.0001 |
| 930 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
2 |
0.0001 |
| 931 |
BALANCE DISORDER |
6 |
0.0001 |
| 932 |
VAGINAL HAEMORRHAGE |
3 |
0.0001 |
| 933 |
CATARACT |
4 |
0.0001 |
| 934 |
ABDOMINAL DISTENSION |
7 |
0.0001 |
| 935 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
3 |
0.0001 |
| 936 |
RENAL DISORDER |
3 |
0.0001 |
| 937 |
NO ADVERSE EVENT |
11 |
0.0001 |
| 938 |
FALL |
20 |
0.0001 |
| 939 |
CHEST PAIN |
11 |
0.0001 |
| 940 |
CHEST DISCOMFORT |
6 |
0.0001 |
| 941 |
ERYTHEMA |
12 |
0.0001 |
| 942 |
MUSCULOSKELETAL PAIN |
3 |
0.0001 |
| 943 |
CONSTIPATION |
12 |
0.0001 |
| 944 |
AGITATION |
4 |
0.0001 |
| 945 |
ARTHROPATHY |
3 |
0.0001 |
| 946 |
DYSGEUSIA |
4 |
0.0001 |
| 947 |
BLISTER |
3 |
0.0001 |
| 948 |
HALLUCINATION |
4 |
0.0001 |
| 949 |
FLATULENCE |
3 |
0.0001 |
| 950 |
CONTUSION |
5 |
0.0001 |
| 951 |
BLADDER CANCER |
3 |
0.0001 |
| 952 |
PAIN IN EXTREMITY |
15 |
0.0001 |
| 953 |
FLUSHING |
5 |
0.0000 |
| 954 |
AMNESIA |
3 |
0.0000 |
| 955 |
MYOCARDIAL INFARCTION |
8 |
0.0000 |
| 956 |
BLOOD PRESSURE DECREASED |
3 |
0.0000 |
| 957 |
PRURITUS |
17 |
0.0000 |
| 958 |
INJECTION SITE REACTION |
3 |
0.0000 |
| 959 |
OROPHARYNGEAL PAIN |
4 |
0.0000 |
| 960 |
SWELLING |
4 |
0.0000 |
| 961 |
TREMOR |
7 |
0.0000 |
| 962 |
DYSPEPSIA |
4 |
0.0000 |
| 963 |
SYNCOPE |
4 |
0.0000 |
| 964 |
ACNE |
3 |
0.0000 |
| 965 |
HYPERHIDROSIS |
5 |
0.0000 |
| 966 |
BACK PAIN |
9 |
0.0000 |
| 967 |
PSORIASIS |
5 |
0.0000 |
| 968 |
MYALGIA |
6 |
0.0000 |
| 969 |
INTENTIONAL PRODUCT MISUSE |
3 |
0.0000 |
| 970 |
ABDOMINAL PAIN UPPER |
7 |
0.0000 |
| 971 |
OVERDOSE |
7 |
0.0000 |
| 972 |
HEART RATE INCREASED |
3 |
0.0000 |
| 973 |
DRY SKIN |
4 |
0.0000 |
| 974 |
PAIN |
18 |
0.0000 |
| 975 |
BURNING SENSATION |
2 |
0.0000 |
| 976 |
JOINT SWELLING |
3 |
0.0000 |
| 977 |
ANXIETY |
7 |
0.0000 |
| 978 |
ADVERSE DRUG REACTION |
2 |
0.0000 |
| 979 |
ADVERSE EVENT |
2 |
0.0000 |
| 980 |
MALAISE |
9 |
0.0000 |
| 981 |
BLOOD PRESSURE INCREASED |
3 |
0.0000 |
| 982 |
URTICARIA |
3 |
0.0000 |
| 983 |
ABDOMINAL DISCOMFORT |
3 |
0.0000 |
| 984 |
ARTHRALGIA |
7 |
0.0000 |
| 985 |
DIZZINESS |
8 |
0.0000 |
| 986 |
BLOOD GLUCOSE INCREASED |
3 |
0.0000 |
| 987 |
INSOMNIA |
4 |
0.0000 |